Macleods gets FDA nod for generic Actos

02/11/2013 | Drug Store News

Macleods Pharma received FDA approval for its pioglitazone hydrochloride tablets in three strengths: 15 mg, 30 mg and 45 mg. The drug is a generic formulation of the diabetes treatment Actos, made by Takeda.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ